NCT06590961
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06590961
Title UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ubix Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL

Facility Status City State Zip Country Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
Gabrail Cancer Center RECRUITING Canton Oklahoma 44718 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
MICS Centrum Medyczne Toruń NOT_YET_RECRUITING Torun Kuyavian-Pomeranian Voivodeship 87-100 Poland Details
Pratia, MTZ Clinical Research NOT_YET_RECRUITING Warsaw Mazowieckie Voivodeship 02-172 Poland Details
Pratia, Oncology Katowice NOT_YET_RECRUITING Katowice Silesian Voivodeship 40-519 Poland Details
AidPort NOT_YET_RECRUITING Grodzisk Wielkopolski Wielkopolskie Voivodeship 62-065 Poland Details
Asan Medical Center RECRUITING Seoul Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul Seoul 06351 South Korea Details
The Catholic University of Korea, Seoul St. Mary's Hospital RECRUITING Seoul Seoul 06591 South Korea Details
The Catholic University of Korea, Yeouido St. Mary's Hospital RECRUITING Seoul Seoul 07345 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field